Drug class · Pain & inflammation
Opioid agonists Drug Codes & NDCs
Drugs that activate opioid receptors. Most are DEA-scheduled; the schedule is shown on each NDC record.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Belbucabuprenorphine hydrochloride | Buprenorphine hydrochloride 750 ug/1 | Film, SolubleBuccal | BioDelivery Sciences International Inc | 59385-026 |
| Belbucabuprenorphine hydrochloride | Buprenorphine hydrochloride 900 ug/1 | Film, SolubleBuccal | BioDelivery Sciences International Inc | 59385-027 |
| berkley and jensen anti diarrhealloperamide hydrochloride | Loperamide hydrochloride 2 mg/1 | Tablet, Film coatedOral | BJWC | 68391-224 |
| Brixadibuprenorphine | Buprenorphine 8 mg/.16mL | InjectionSubcutaneous | Braeburn Inc. | 58284-208 |
| Brixadibuprenorphine | Buprenorphine 16 mg/.32mL | InjectionSubcutaneous | Braeburn Inc. | 58284-216 |
| Brixadibuprenorphine | Buprenorphine 24 mg/.48mL | InjectionSubcutaneous | Braeburn Inc. | 58284-224 |
| Brixadibuprenorphine | Buprenorphine 128 mg/.36mL | InjectionSubcutaneous | Braeburn Inc. | 58284-228 |
| Brixadibuprenorphine | Buprenorphine 32 mg/.64mL | InjectionSubcutaneous | Braeburn Inc. | 58284-232 |
| Brixadibuprenorphine | Buprenorphine 64 mg/.18mL | InjectionSubcutaneous | Braeburn Inc. | 58284-264 |
| Brixadibuprenorphine | Buprenorphine 96 mg/.27mL | InjectionSubcutaneous | Braeburn Inc. | 58284-296 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Hikma Pharmaceuticals USA Inc. | 0054-0176 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Hikma Pharmaceuticals USA Inc. | 0054-0177 |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3239 |
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3656 |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3657 |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3658 |
| Buprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3659 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Actavis Pharma, Inc. | 0228-3153 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Actavis Pharma, Inc. | 0228-3156 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Major Pharmaceuticals | 0904-7154 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Major Pharmaceuticals | 0904-7155 |
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1521 |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1522 |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1523 |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1524 |